for ascites tumors , maximum increases in lifespan ( using 6 -- 12 mg/kg q2d x 5 ) with 10-deaza-aminopterin versus methotrexate were + 171.2 % /+ 149.8 % against l1210 leukemia , +118.4 % /+109.1 % against p815 plasmacytoma , +64 % /+20.9 % against ehrlich ascites carcinoma , +84.2 % /+44.8 % against taper liver tumor , and greater than +159.6 % /+64.0 % against sarcoma 180 with longterm survivors after 10-deaza-aminopterin .
C0007125
ascites tumors
C0007097
carcinoma